Search

Your search keyword '"Varano S"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Varano S" Remove constraint Author: "Varano S"
68 results on '"Varano S"'

Search Results

1. An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder

2. In-Situ Particle Acceleration in Extragalactic Radio Hot Spots: Observations Meet Expectations

3. Chandra detection of the radio and optical double hot spot of 3C 351

8. The wound and the leg amputation of Giovanni dalle Bande Nere (1498-1526): life and death of a mercenary captain of the italian renaissance

18. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

19. Exploring the mitochondrial DNA variability of the Amazonian Yanomami

20. L'insegnamento della fisica nel biennio dei licei della nuova riforma

21. Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

31. Expérimentation d’un EVE pour la co-création spatiale et pédagogique

32. Lung Ultrasound Score Progress in Neonatal Respiratory Distress Syndrome

33. Food at the heart of the Empire: dietary reconstruction for Imperial Rome inhabitants

34. Dietary and Weaning Habits of the Roman Community of Quarto Cappello del Prete (Rome, 1st-3rd Century CE)

35. The edge of the Empire. Diet characterization of medieval Rome through stable isotope analysis

36. Whole genome sequencing analysis of alpaca suggests TRPV3 as a candidate gene for the suri phenotype.

37. Plain language summary: does treatment with vibegron result in improvements in overactive bladder (OAB) symptoms that are meaningful to people with OAB?

38. Plain language summary of safety and symptom improvement with vibegron in people with overactive bladder: results from the EMPOWUR study.

39. Phenotypic Correlation between Guard Hair and Down Hair in Chinese Alashan Left Banner White Cashmere Goat: A Preliminary Study.

40. Efficacy and Safety of Vibegron for the Treatment of Overactive Bladder in Women: A Subgroup Analysis From the Double-Blind, Randomized, Controlled EMPOWUR Trial.

41. Dog-human translational genomics: state of the art and genomic resources.

42. Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial.

43. Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWUR.

44. Neonatal Lung Ultrasound and Surfactant Administration: A Pragmatic, Multicenter Study.

45. Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR).

47. Vibegron improves quality-of-life measures in patients with overactive bladder: Patient-reported outcomes from the EMPOWUR study.

48. Lung Ultrasound Score Progress in Neonatal Respiratory Distress Syndrome.

49. Efficacy and Safety of Once-Daily Vibegron for Treatment of Overactive Bladder in Patients Aged ≥65 and ≥75 Years: Subpopulation Analysis from the EMPOWUR Randomized, International, Phase III Study.

50. Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.

Catalog

Books, media, physical & digital resources